PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Healthcare Delivery Innovation Center, Minneapolis Heart Institute, 920 East 28th Street, Suite 300, Minneapolis, MN, 55407, USA. Steven.Bradley@allina.com.\', \'Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA.\', \'Northwestern University Feinberg School of Medicine, Chicago, IL, USA.\', \'Division of Cardiovascular Medicine, Cardiovascular Institute, Stanford University, Stanford, CA, USA.\', \'Department of Medicine, Emory Heart and Vascular Center, Emory University School of Medicine, Atlanta, USA.\', \'Center for Cardiovascular Analytics, Research and Data Science (CARDS), Providence Heart Institute, Portland, OR, USA.\', \'Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.\', \'Duke Clinical Research Institute, Duke University, Durham, NC, USA.\', \'Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.\', \'Center for Outcomes Research and Evaluation, Yale-New Haven Health, New Haven, CT, USA.\', \'Denver Health Medical Center, Denver, CO, USA.\', \'University of Colorado Anschutz Medical Center, Aurora, CO, USA.\', \'Center for Innovation and Value at Parkland, University of Texas Southwestern Medical Center, Dallas, TX, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-94203-7
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34302004
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all